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Abstract
Aims: To estimate the number of coronary heart disease (CHD) deaths potentially preventable in England in 2020
comparing four risk factor change scenarios.
Methods and Results: Using 2007 as baseline, the IMPACTSEC model was extended to estimate the potential
number of CHD deaths preventable in England in 2020 by age, gender and Index of Multiple Deprivation 2007
quintiles given four risk factor change scenarios: (a) assuming recent trends will continue; (b) assuming optimal but
feasible levels already achieved elsewhere; (c) an intermediate point, halfway between current and optimal levels;
and (d) assuming plateauing or worsening levels, the worst case scenario. These four scenarios were compared to
the baseline scenario with both risk factors and CHD mortality rates remaining at 2007 levels. This would result in
approximately 97,000 CHD deaths in 2020. Assuming recent trends will continue would avert approximately 22,640
deaths (95% uncertainty interval: 20,390-24,980). There would be some 39,720 (37,120-41,900) fewer deaths in
2020 with optimal risk factor levels and 22,330 fewer (19,850-24,300) in the intermediate scenario. In the worst case
scenario, 16,170 additional deaths (13,880-18,420) would occur. If optimal risk factor levels were achieved, the gap
in CHD rates between the most and least deprived areas would halve with falls in systolic blood pressure, physical
inactivity and total cholesterol providing the largest contributions to mortality gains.
Conclusions: CHD mortality reductions of up to 45%, accompanied by significant reductions in area deprivation
mortality disparities, would be possible by implementing optimal preventive policies.
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Introduction
Recent UK declines in the rate of coronary heart disease
(CHD) mortality have been impressive. The wider use of
treatments among people with CHD explains around half the
recent fall [1]. Just over one third is explained by population
trends in major cardiovascular risk factors, namely falls in blood
pressure, cholesterol, and smoking negated in part by
increasing obesity and diabetes.
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However, an ageing population will increase the CHD
burden. Relative inequalities have persisted as CHD mortality
rates have fallen more slowly in the most deprived areas [2].
Risk factor levels in England remain above both previous
government targets and best levels achieved internationally.
Inequalities in risk factors in England have likewise shown little
or no improvement since 1994. Absolute inequalities in obesity
and diabetes have widened, reflecting recent larger increases
in the most deprived areas [3].
Estimating potential reductions in CHD deaths through
decreases in modifiable risk factors would help policy-makers.
In this modelling study, we assessed the potential contribution
of risk factor reduction on future CHD mortality levels, and on
absolute and relative inequalities, using the IMPACTSEC model
which quantifies the relative contributions of risk factor trends
and treatment uptake to recent declines in CHD mortality in
England [1]. Our base year was 2007 and the model was
extended to 2020 to estimate the impact of four feasible risk
factor change scenarios. 2020 was chosen as being sufficiently
close to allow reasonable predictions and therefore be of direct
policy relevance.
Methods
IMPACTSEC model
The IMPACTSEC model is described in detail elsewhere [1].
Briefly, the model quantifies the contribution of risk factor
trends (smoking, systolic blood pressure (SBP), cholesterol,
body mass index (BMI), diabetes, and physical activity) and
changes in uptake of treatments to changes in CHD mortality
rates in England. For this study we focussed exclusively on
changes in risk factor levels in the population as a whole.
We used two validated methods to quantify the relationship
between risk factor change and the consequent change in CHD
mortality. First, the regression method is based on beta
coefficients from large meta-analyses which summarise the
independent mortality effects of changes in risk factors
measured on a continuous scale - total cholesterol, BMI, and
SBP [4–7]. We estimated the numbers of CHD deaths
prevented/postponed (DPPs) in 2020 as a product of deaths
expected in 2020 (assuming no change in CHD rates from
2007), absolute change in average risk factor levels between
2007 and 2020, and the beta coefficient. Second, population
Table 1. Risk factor levels in England in 2007 and 2020 by risk factor change scenario.
Risk factor 2007 2020 scenarios
 Baseline Worst case Current trends Intermediate Optimal
Smoking (%)      
All 22.9 22.9 16.8 16.5 10.0
Men 24.4 24.4 20.7 17.2 10.0
Women 21.5 21.5 12.9 15.7 10.0
Physical inactivity (%)      
All 74.6 74.6 65.8 52.3 30.0
Men 73.4 73.4 63.7 51.7 30.0
Women 75.8 75.8 67.9 52.9 30.0
Diabetes (%)      
All 5.4 15.0 11.3 4.7 4.0
Men 6.3 17.6 11.7 5.5 4.7
Women 4.4 12.4 10.8 3.9 3.3
Systolic Blood Pressure
(mmHg)      
All 127.4 127.4 120.3 122.4 117.4
Men 130.8 130.8 126.6 125.8 120.8
Women 124.0 124.0 114.0 119.0 114.0
Total cholesterol
(mmol/l)      
All 5.5 5.5 5.3 5.2 4.9
Men 5.5 5.5 5.3 5.2 4.9
Women 5.5 5.5 5.2 5.2 4.9
Body mass index
(kg/m2)      
All 27.5 29.4 28.3 26.3 25.0
Men 27.8 29.6 28.6 26.8 25.9
Women 27.3 29.1 27.9 25.7 24.1
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attributable risk fractions (PARF) calculated using Levin’s
formula quantified the impact of change in three binary risk
factors - current smoking, physical inactivity, and diabetes [8].
We calculated DPPs in 2020 as a product of deaths expected
in 2020 and absolute change in PARF between 2007 and
2020.
Estimating combined effects of risk factor change
Beta coefficients and relative risks were age- and gender-
specific but were assumed equal across socioeconomic
groups. The number of DPPs attributable to individual risk
factors cannot be added due to overlap between them because
of multi-causality and because the effects of some risk factors
are partly mediated through other risk factors (e.g., the effects
of BMI on CHD mortality are partly mediated through SBP and
usual fasting plasma glucose) [9]. The combined impact of all
risk factors was therefore estimated using the standard formula
that accounts for multi-causality [1,10,11]. For example, given
PARF values of 0.231, 0.286 and 0.021 for three risk factors
the PARF formula accounting for multi-causality equals 1-
((1-0.231)×(1-0.286)×(1-0.021)) = 0.462, a mortality reduction
lower (i.e., more conservative) than the additive value of 0.538.
The combined effect of change in all risk factors was calculated
by age, gender, and socioeconomic group. Detailed information
on our modelling approach is provided as supporting
information in Text S1.
Contribution of each risk factor to mortality gain
The percentage contribution of each risk factor to mortality
gain was calculated separately for continuous and binary
variables. The former equalled the relative change in CHD
mortality associated with absolute change; the latter equalled
absolute change in the PARF.
Area deprivation, baseline mortality rates and projected
population numbers
Area deprivation was defined using the Index of Multiple
Deprivation (IMD) 2007 with small areas grouped into quintiles,
ranked from Q1 (least deprived) to Q5 (most deprived) [12].
CHD (International Classification of Diseases ICD-10: I20-I25)
deaths in 2007 by gender, age-group (in 10-y bands, 25-34 to
age ≥ 85 years) and IMD quintile were obtained from the Office
for National Statistics. Corresponding population denominators
in 2020 were estimated using population projection methods.
Estimating changes in absolute and relative
inequalities by 2020
Expected deaths from CHD in 2020 were calculated
assuming no change in gender-, age- and IMD quintile-specific
mortality rates. Mortality rates in 2020 in each scenario were
calculated by dividing expected CHD deaths not prevented by
the 2020 population. We calculated age-standardised rate
differences and rate ratios between Q1 and Q5 and their
Table 2. CHD deaths prevented/postponed in 2020 by risk factor change scenario.
 Population (per 1000) CHD mortality rate (per 100,000)a Expected deaths Deaths prevented/postponed (DPPs)b
 2020 2007 2020 2020
    Worst case Current trends Intermediate Optimal
All        
Englandc 39,787 147.4 97,059 16,170 -22,640 -22,330 -39,720
Q1 8,651 108.9 18,284 2,670 -4,370 -3,930 -7,070
Q2 8,476 125.1 20,382 3,190 -5,000 -4,500 -8,060
Q3 8,182 141.8 20,579 3,540 -4,330 -4,650 -8,280
Q4 7,633 169.1 19,483 3,160 -4,610 -4,580 -8,120
Q5 6,846 214.0 18,331 3,610 -4,320 -4,690 -8,200
Men        
Englandc 19,462 200.3 57,270 8,700 -12,820 -13,140 -23,340
Q1 4,209 148.1 10,998 1,410 -2,660 -2,340 -4,210
Q2 4,130 169.5 12,021 1,770 -2,700 -2,640 -4,720
Q3 4,001 192.6 12,021 2,010 -2,590 -2,710 -4,820
Q4 3,753 230.2 11,283 1,650 -2,510 -2,660 -4,700
Q5 3,369 292.6 10,946 1,860 -2,350 -2,800 -4,890
Women        
Englandc 20,325 94.6 39,789 7,470 -9,820 -9,190 -16,380
Q1 4,442 69.7 7,287 1,260 -1,710 -1,590 -2,860
Q2 4,345 80.8 8,361 1,420 -2,300 -1,860 -3,340
Q3 4,180 91.0 8,557 1,530 -1,740 -1,940 -3,460
Q4 3,881 108.0 8,200 1,510 -2,100 -1,920 -3,420
Q5 3,477 135.5 7,384 1,750 -1,970 -1,890 -3,310
a Age-standardised.
b DPPs rounded to nearest 10: positive DPPs represent adverse trends; negative DPPs show risk factor reduction.
c Summation of IMD quintile counts.
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percentage reduction from 2007. Direct age-standardisation
was computed using the European Standard Population.
Risk factor data and risk factor change scenarios
Risk factor data from 1994 to 2008 were obtained from the
Health Survey for England (HSE). Sampling methods and data
collection instruments are described in detail elsewhere
[1,3,13]. (See Table C in Text S1 for risk factor definitions.)
Previous modelling studies quantified mortality gains from
maximum risk factor reduction or achievement of “low-risk”
levels [14,15]. Such aspirational scenarios appear unlikely and
may therefore be less relevant to policy-makers. Instead, we
defined four more realistic scenarios, based on recent national
and international trends, and compared these to a baseline
scenario of no change (Table 1). Each scenario is described
below.
Baseline scenario. Assuming no change in risk factor
levels or CHD mortality rates.  Risk factor levels and CHD
rates in 2007 would persist unchanged to 2020.
Scenario 1. Assuming current trends
continue.  Fractional polynomial functions to accommodate
possible non-linearity were fitted to the HSE data with the risk
factor as dependent variable and survey year as explanatory
variable [16]. Best-fitting functions fitted to 1994-2008 data
were projected forward to 2020. Separate models were fitted
by gender, age and deprivation quintile. Due to small numbers
we used an upper age band of ≥75 years.
Scenario 2. Achievement of optimal levels.  Where
possible we applied optimal levels observed internationally.
SBP falls of ≥10 mmHg have been observed since 1980 in
Finland, France, Iceland and Switzerland, and so a 10 mmHg
fall was considered plausible for an optimal scenario [17].
Likewise, falls in total cholesterol of 0.6 mmol/l since 1980 have
occurred in the US and several Nordic countries [18,19]. BMI
levels were set at the lowest levels currently observed in
Western Europe (men: 25.9 kg/m2 in France; women: 24.1
kg/m2 in Switzerland) [20]. For other risk factors, we applied
target levels. Thus: reducing smoking levels to a target of 10%
by 2020 was outlined in the previous government’s tobacco
control strategy, A Smokefree Future [21]. Game Plan, the
previous government’s strategy for delivering physical activity
objectives, stated that 70% of adults should undertake ≥ 30
Figure 1.  Reduction in CHD deaths in 2020 by risk factor change scenario.  DPPs, deaths prevented or postponed. Q1 = least
deprived; Q5 = most deprived. Positive DPPs show additional deaths representing adverse risk factor trends; negative DPPs show
risk factor reduction. 95% uncertainty intervals shown by I bars.
doi: 10.1371/journal.pone.0069935.g001
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minutes of moderate-to-vigorous activities on at least five days
a week by 2020 [22].
Finally, UK governments have not set targets to reduce
diabetes levels which currently lie close to the European
average of 5% [23]. Our optimal target was set at 4%,
consistent with current levels in Sweden [23].
Scenario 3. Intermediate levels halfway between current
and optimal levels.  Achieving optimal levels represents a
major challenge. Recent increases in BMI and diabetes, for
example, must be successfully halted before being reduced to
optimal levels. Hence we defined an intermediate scenario in
which risk factor levels reach a point halfway between current
and optimal levels, as defined above.
Scenario 4. Worst case scenario: plateauing or
worsening trends.  Levelling-off in SBP declines was recently
observed in the US and Finland and so we assumed no
change in mean SBP levels [20,24]. Cholesterol levels in
younger age groups in the US have stabilised, therefore no
change was also assumed for total cholesterol [20]. Recent
plateauing in obesity [25] is not inevitable and so we assumed
annual increases in BMI of 0.5%, similar to increases in the US
over 1990-2005 [26]. Increasing diabetes levels in England in
older groups reflect BMI increases and improved case-
ascertainment. The APHO Diabetes Prevalence Model 2020
estimate is 8.5% reflecting population change and BMI
increases [27] - but such models may underestimate likely
improvements in survival for diabetic people [28]. Diabetes
levels were therefore assumed to reach 15% in 2020 (from 5%
at baseline).
Deprivation gradients in risk factor levels
Previous studies examined mortality gains through: (1) equal
absolute change in risk factors across social groups, (2)
improvement in least advantaged groups to levels achieved in
the most advantaged, and (3) proportional change (optimal
levels achieved overall but with no change in socioeconomic
gradients) [14,29,30]. We assumed proportional change in risk
factor levels in optimal, intermediate, and worst case scenarios
and used IMD quintile specific projections in the current trends
scenario.
Uncertainty analysis
Monte Carlo simulation using the Excel add-in Ersatz was
used to compute 95% uncertainty intervals (UIs) of deaths
prevented in each scenario. This involved replacing all fixed
input parameters by appropriate probability distributions, and
repeatedly recalculating model outputs with values sampled
from the defined input distributions [31]. 95% UIs using the 2.5th
and 97.5th percentiles were generated from 1000 model
iterations.
Table 3. 2020 mortality rates by risk factor change scenario.
Scenarios CHD mortality rate in 2020 (per 100,000)a Relative change (%)b
 Englandc Q1 Q2 Q3 Q4 Q5 Englandc Q1 Q2 Q3 Q4 Q5
All             
Baseline2007 147.4 108.9 125.1 141.8 169.1 214.0 − − − − − −
Worst case 171.5 124.7 144.4 165.8 197.0 256.2 16.9 15.2 15.8 17.2 17.2 20.7
Current trends 113.0 83.3 93.9 110.2 128.9 162.2 -23.8 -23.6 -26.2 -22.7 -23.9 -24.5
Intermediate 110.5 83.3 94.7 106.2 124.7 153.6 -25.1 -23.5 -24.4 -25.1 -26.4 -28.4
Optimal 82.9 63.6 71.5 79.5 91.7 110.0 -43.9 -41.7 -43.0 -44.1 -45.9 -48.8
Men             
Baseline2007 200.3 148.1 169.5 192.6 230.2 292.6 − − − − − −
Worst case 230.9 167.6 194.4 224.4 265.2 344.9 15.2 13.2 14.7 16.5 15.2 17.9
Current trends 155.1 113.5 131.0 151.3 175.9 223.1 -22.6 -23.3 -22.7 -21.4 -23.6 -23.7
Intermediate 150.4 113.5 128.5 144.6 170.1 210.8 -24.9 -23.3 -24.2 -24.9 -26.1 -28.0
Optimal 113.1 86.9 97.3 108.5 125.5 151.5 -43.5 -41.3 -42.6 -43.6 -45.5 -48.2
Women             
Baseline2007 94.6 69.7 80.8 91.0 108.0 135.5 − − − − − −
Worst case 112.2 81.7 94.4 107.3 128.8 167.4 18.6 17.3 16.9 17.9 19.3 23.6
Current trends 71.0 53.1 56.8 69.1 82.0 101.2 -24.9 -23.8 -29.7 -24.0 -24.1 -25.3
Intermediate 70.6 53.2 60.9 67.9 79.2 96.4 -25.4 -23.7 -24.6 -25.4 -26.7 -28.8
Optimal 52.6 40.3 45.7 50.5 57.9 68.4 -44.4 -42.1 -43.4 -44.5 -46.4 -49.5
a Age-standardised.
b Positive values represent increasing mortality rates; negative values show declines.
c Expected deaths and DPPs summed over IMD quintiles.
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Ethics statement
Each sampled address for the Health Survey for England is
sent an advance letter which introduces the survey and states
that an interviewer would be calling to seek permission to
interview. A leaflet is also enclosed providing general
information about the survey and some of the findings from
previous surveys. Individual interviews are conducted with
adults who give verbal informed consent. At the end of
individual interviews, participants are asked for agreement to a
follow-up visit by a trained nurse. Written consent is obtained
for collection of non-fasting blood samples.
There is no formal record that participants have given verbal
consent to the individual interview or give physical
measurements that are not biological samples (e.g., height,
weight, and blood pressure). It is made clear in the advance
letters and information leaflets that participation in the survey is
entirely voluntary, and that participants may decline to answer
individual questions, withdraw or stop at any time, or refuse
any particular measurement if they wish to do so. Interviewers
and nurses will often repeat this information in their
introductions and when they are setting up appointments, and
throughout the interview as necessary. Indeed, many
individuals do refuse to participate in the survey: others may
refuse individual questions, decline to continue part way
through an interview or refuse physical measurements. It is
also standard practice to conduct interviews and nurse visits
some time after an appointment has been made so that
individuals have to a chance to reflect on their agreement
before the appointment takes place.
The procedures used in the Health Survey for England to
obtain informed consent are very closely scrutinised by a
National Health Service (NHS) ethics committee each year.
Information leaflets and both the content and wording of
questionnaires are also carefully reviewed by the ethics
committees.
All Local Research Ethics Committees (LREC) in England
were approached for ethical approval of the 1994 survey before
it started. All gave their approval, with the exception of
Shropshire and Northallerton. Sampled addresses within these
areas were withdrawn from the survey. In addition, agreement
could not be reached with East Birmingham LREC in time to
cover selected addresses during the first quarter of fieldwork.
These addresses therefore were not covered.
All LRECs in England were approached for ethical approval
for the 1995 survey before it started. All gave their approval,
with the exception of Shropshire and the Isle of Wight.
Sampled addresses within these areas were withdrawn from
the survey. All LRECs in England, with two exceptions, were
approached for ethical approval in both 1996 and 1997. All
gave their approval. As the 1996 and 1997 designs were
similar to that of 1995, agreement from the Shropshire and Isle
of Wight LRECs was not sought for either survey. The areas
covered by these two committees were omitted from the
sample selection process.
Ethical approval for each survey between 1998 and 2001
was obtained from the North Thames Multi-centre Research
Ethics Committee (MREC) and from all LRECs in England;
approval for each survey between 2002 and 2007 was
obtained from the London Multi-Centre Research Ethics
Committee. Ethical approval for the 2008 survey was obtained
from the Oxford A Research Ethics Committee (reference
number 07/H0604/102).
Table 4. Changes in inequalities by risk factor change scenario.
Scenarios CHD mortality ratea Inequalities
 In 2020 (per 100,000) Absolute Relative
 Englandb Q1 Q5 Difference Change (%)c Ratio Change (%)c
Men        
Baseline2007 200.3 148.1 292.6 144.5 − 1.98 −
Worst case 230.9 167.6 344.9 177.3 -22.7 2.06 -8.5
Current trends 155.1 113.5 223.1 109.6 24.1 1.97 1.0
Intermediate 150.4 113.5 210.8 97.2 32.7 1.86 12.2
Optimal 113.1 86.9 151.5 64.6 55.3 1.74 23.8
Women        
Baseline2007 94.6 69.7 135.5 65.8 − 1.94 −
Worst-case 112.2 81.7 167.4 85.7 -30.3 2.05 -11.1
Current trends 71.0 53.1 101.2 48.1 26.9 1.91 4.1
Intermediate 70.6 53.2 96.4 43.3 34.2 1.81 13.8
Optimal 52.6 40.3 68.4 28.1 57.3 1.70 26.2
a Age-standardised rates.
b Calculated using expected deaths and DPPs summed over IMD quintiles.
c Positive values show inequality reductions; negative values show increases.
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Our study, pooling Health Survey for England data from
1994–2008 to inform projections for the current trends
scenario, is a secondary analysis of previously collected data
and so additional ethical approval was not required.
Results
Table 1 shows risk factor levels in 2007 and 2020 for each
scenario. Socioeconomic gradients in 2007 were strongest for
smoking, diabetes, physical activity, and BMI in women (Table
E in Text S1). Table 2 shows the CHD deaths prevented/
postponed (DPPs) in each scenario and Figure 1 shows
accompanying 95% uncertainty intervals; Table 3 shows the
estimated changes in CHD mortality rates over the 13-y period
(For age-specific results see Tables K–N in Text S1).
Estimated CHD mortality in 2020 based on different
scenarios
Baseline scenario. Assuming no change in risk factor
levels or CHD mortality rates.  Approximately 97,000 CHD
deaths would be expected in 2020. This would represent 30%
more deaths than in 2007, simply reflecting population ageing
(Table 2).
Scenario 1. Assuming current trends
continue.  Approximately 22,640 (95% uncertainty interval:
20,390-24,980) fewer CHD deaths would occur in 2020 should
current risk factor trends continue compared to the baseline of
no change: 12,820 in men (11,140-14,480) and 9,820 in
women (8,230-11,360). This would represent the net of 28,800
deaths prevented due to falls in smoking, physical inactivity,
SBP and total cholesterol negated by 6,160 additional deaths
through increases in BMI and diabetes. Relative reductions in
CHD mortality rates would be broadly similar across IMD
quintiles (men: 23% in Q1 and 24% in Q5; women: 24% in Q1
and 25% in Q5) (Table 3).
Scenario 2. Achievement of optimal levels.  Achieving
optimal levels would prevent approximately 39,720 deaths
(37,120-41,900). 23,340 deaths would be averted in men
(21,390-25,100); 16,380 in women (14,740-17,820). DPPs
would be highest in the most deprived areas (men: 4,210 in Q1
and 4,890 in Q5; women: 2,860 in Q1 and 3,310 in Q5). CHD
mortality rates would fall to 45% of 2007 levels, with relative
reductions just below 50% in both sexes in Q5 compared with
41% in men and 42% in women in Q1 (Table 3).
Figure 2.  Risk factor contributions to mortality gains in 2020 in men by risk factor change scenario.  Q1 = least deprived;
Q5 = most deprived. SBP: systolic blood pressure; BMI: body mass index.
doi: 10.1371/journal.pone.0069935.g002
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Scenario 3. Intermediate levels halfway between current
and optimal levels.  Deaths prevented in the intermediate
scenario would be similar to the current trends scenario
(22,330 (19,850-24,300) fewer deaths). The pattern of risk
factor change would however be very different. The
intermediate scenario assumed: (1) falls, rather than increases,
in BMI and diabetes; (2) larger reductions in smoking and
physical inactivity; and (3) more modest falls in SBP and
cholesterol.
Scenario 4.Worst case scenario: plateauing or
worsening trends.  Roughly 16,170 (13,880-18,420)
additional CHD deaths would be expected in the worst case
scenario: 8,700 in men (7,190-10,030) and 7,470 in women
(5,800-9,270), reflecting continuing increases in BMI and
diabetes. Assuming proportional change in BMI and diabetes
across IMD quintiles implies larger increases in absolute terms
in quintiles with the highest baseline levels. As BMI and
diabetes are socially patterned, especially in women, additional
deaths would be larger in the most deprived areas: 3,610 in Q5
(3,040-4,200) compared with 2,670 in Q1 (2,120-3,210).
Changes in absolute and relative inequalities by 2020
Table 4 shows the baseline CHD rates in Q1 and Q5 and the
percentage reduction in age-standardised rate differences and
rate ratios. Assuming current risk factor trends continue the
absolute gap in rates between Q1 and Q5 would fall by
approximately 25% (men: 24%; women: 27%). However the
reduction in rate ratios would be negligible (1% and 4% in men
and women, respectively). Achieving optimal levels would
reduce absolute differences by 55% in men and 57% in
women. Rate ratios would fall by 24% and 26% in men and
women, respectively. Rate differences in the intermediate
scenario would fall by roughly 33%, with a 13% reduction in the
rate ratio. Absolute disparities in CHD rates under the worst
case scenario would increase by 23% and 30%, whilst
inequalities in relative terms would increase by 9% and 11% in
men and women, respectively.
Contribution of each risk factor to mortality gain
Figure 2 (men) and 3 (women) show the contribution of each
risk factor to CHD mortality change. SBP falls would provide
the largest contribution, with benefits spread equitably across
IMD quintiles. Due to the current social patterning, larger
Figure 3.  Risk factor contributions to mortality gains in 2020 in women by risk factor change scenario.  Q1 = least deprived;
Q5 = most deprived. SBP: systolic blood pressure; BMI: body mass index.
doi: 10.1371/journal.pone.0069935.g003
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absolute declines in smoking, diabetes and BMI (especially in
women) in the optimal and intermediate scenarios would
achieve larger benefits in the most deprived areas. In the
optimal scenario, falls in SBP would reduce CHD deaths by
roughly 20% in both sexes; achieving the physical activity
target would reduce CHD deaths by 12% (in both sexes) and
10% would be averted by declines in total cholesterol (11% and
8% in men and women, respectively).
Discussion
We estimated the impact of four realistic risk factor scenarios
on levels of CHD mortality and inequalities in England in 2020.
Population ageing would result in approximately 23,000
additional CHD deaths if risk factors remain at 2007 levels. But,
if recent risk factor trends continue, nearly 23,000 deaths might
be averted. In the optimal scenario, approximately 40,000
deaths might be prevented, reducing inequalities by 56% in
absolute terms and 25% in relative terms. The intermediate
scenario would prevent a similar number of deaths as the
current trends scenario but would reduce inequalities more with
reductions of 33% and 13% in absolute and relative terms,
respectively. Over 16,000 additional deaths with increases in
rate disparities would be anticipated in the worst case scenario.
Comparisons with other studies
Our conclusions correspond with previous modelling studies.
A recent US study considered proportional achievement of
Healthy People 2010 targets [30]. Absolute falls in the 10-year
risk of CHD mortality would be 28% in both sexes, with relative
reductions 9%. Inequalities in absolute terms would fall by 35%
in men and 47% in women; relative inequalities would fall by
17% and 30%. A UK prospective cohort study (Whitehall study
of male civil servants) considered reductions in the 15-year risk
of CHD mortality under two scenarios: (1) implementing best-
practice interventions in high and low employment grades, and
(2) primordial prevention (low lifetime risk factor levels) [14].
CHD mortality in the two scenarios would fall by 57% and 73%.
Absolute differences in risk would decrease by 69% and 86%;
reductions in relative terms by 30% and 53%.
The larger reductions in absolute rather than relative
inequalities in our study arise from two main reasons. First,
given the persistent inequalities in risk factor levels in England
since the early 1990s we assumed proportional change in our
scenarios, i.e. equalising relative change across IMD quintiles
while varying absolute change. Second, shifting the entire
population distribution in risk factors that are not socially
patterned can still powerfully reduce inequalities as absolute
risk reduction will be greatest in groups with the highest
baseline mortality rates [32]. This is especially relevant in
England as our previous analyses found no social patterning in
mean levels of SBP and total cholesterol - two of the three
most powerful risk factors for cardiovascular disease [3].
Choosing different scenarios would have produced different
results. Levelling-up risk factor levels in the most deprived
areas to current levels in the least deprived implies equal
reductions in absolute and relative inequalities [30] – but such
a scenario seems unrealistic. Targeting improvement in the
most deprived areas would impact strongly on absolute and
relative inequalities but would have modest impact on overall
mortality levels [30]. Furthermore, this scenario, implying an
uneven distribution of resources, might not be accepted by
those living in less deprived areas.
Strengths and limitations
The IMPACTSEC model has successfully explained recent
change in CHD mortality across age, gender and deprivation
quintiles in England, and in other countries and over different
time periods. Previous work by the authors showed that the
model parameters had face validity in that the model explained
approximately 90% of the observed decline in CHD mortality
between 2000 and 2007 [1]. Our aim in this study was not to
provide a definitive prediction of future CHD mortality levels but
rather to use an established model to explore the mortality
impact of different but plausible scenarios of risk factor
reduction.
We used UK and international risk factor trend data to inform
our scenarios and we summarised potential inequality
reductions in both absolute and relative terms. The findings
however need to be considered in light of our key modelling
assumptions.
Beta coefficients and relative risks (RRs) were assumed to
accurately reflect causality [29]. The estimates of RRs used as
input to the PARF calculations were developed by expert
working groups for the World Health Organization’s Global
Burden of Disease 2001 study and were adjusted for
correlation between risk factors, confounding and mediation
[33,34]. The standard formula used to account for multi-
causality assumes that: (1) exposures to risks are uncorrelated,
and that (2) the effect of one risk factor is not mediated through
others [15]. The latter assumption was partly corrected for
through using beta coefficients/RRs adjusted for confounding
effects. However, residual effects may remain [35]. Double-
counting of mortality gains through multi-causality is therefore
likely to have remained in our model to some degree.
It is important to distinguish between a greater CHD burden
in the most deprived areas reflecting higher levels of risk
factors for cardiovascular disease (smoking, physical inactivity,
diabetes and BMI), and effect-modification, whereby the impact
of risk factors may systematically vary across areas with
different deprivation levels. Consistent with recent Health
Survey for England data, our modelling approach allowed risk
factor levels in the baseline year to vary across deprivation
quintiles. Our assumption of proportional risk factor change
meant that the magnitude of falls in risk factor levels over the
13-yr period, in absolute terms, was greater in areas with the
highest baseline levels. However, as in other recent modelling
studies, we have assumed that the percentage decrease in
CHD mortality per unit change in risk factor levels was equal
across deprivation quintiles. This assumption was made due to
the lack of systematic data on whether, and how, the impact of
proximate risk factors on mortality differs by socioeconomic
group. We acknowledge that bias in our model through
assuming equal beta coefficients/RRs across deprivation
quintiles remains possible, but that such bias is unlikely to be
very large. For example, two recent collaborative analyses
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found that the impact of BMI and diabetes on cardiovascular
disease and all-cause mortality respectively showed no
appreciable reduction in age- and gender-adjusted hazard
ratios after additional adjustment for indicators of
socioeconomic status [36,37].
Finally, a geographical index of socioeconomic position
(SEP) was used, the Index of Multiple Deprivation (IMD) 2007.
Area-level categorizations of socioeconomic status are not
perfect proxies for individual-level SEP. However, assigning
individuals to individual-level measures of SEP is not without its
problems. In England, individual-level SEP categories have
changed over time and are particularly problematic for older
people (where the majority of CHD deaths occur). For example,
individual-level measures of social position for those aged 65
and over is not reliably recorded in death certificates [38],
whereas residential address recording is complete and
accurate. Area-level measures of SEP also help to capture the
contextual effects of living conditions [39].
It is likely that some areas will undergo ‘gentrification’ while
others move down the deprivation ladder. In previous work we
tested the assumption of stability in the relative ranking of
deprivation quintile allocation in England across a 20-yr period
(1981-2001) [2,40]. Our results showed that the top and bottom
fifths of the deprivation distribution remained stable over the
two decades. Just over three-quarters (76%) of the population
in 1981 who were living in either the least or most deprived
quintiles remained in their respective top/bottom quintiles in
2001. Hence we would anticipate changes in the deprivation
levels of areas over the time period of our study, but no
dramatic change in the relative stability of quintile membership.
Conclusions
This population-based modelling suggests that at best,
deaths from CHD in 2020 could be reduced by approximately
45% of the level in 2007, with the largest absolute gains
occurring in the most deprived areas.
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